NOVEL HOLLOW-FIBER BIOREACTOR WITH INTEGRAL OXYGENATION

Information

  • Research Project
  • 3507034
  • ApplicationId
    3507034
  • Core Project Number
    R44CA062660
  • Full Project Number
    9R44CA062660-02
  • Serial Number
    62660
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/30/1993 - 30 years ago
  • Project End Date
    9/30/1995 - 28 years ago
  • Program Officer Name
  • Budget Start Date
    9/30/1993 - 30 years ago
  • Budget End Date
    3/31/1994 - 30 years ago
  • Fiscal Year
    1993
  • Support Year
    2
  • Suffix
  • Award Notice Date
    9/29/1993 - 30 years ago

NOVEL HOLLOW-FIBER BIOREACTOR WITH INTEGRAL OXYGENATION

DESCRIPTION: (Adapted from Applicant's Abstract) The objective of this Phase II project is to further develop a newly designed hollow fiber bioreactor. The applicant claims the bioreactor can support five times more viable mammalian cells/ml than existing hollow fiber bioreactors. The phase I project demonstrated that a bioreactor constructed with an internal oxygenation membrane can support mammalian cells in culture. The Phase II project would complete the design of the bioreactor and generate the data required to design and develop a series of mammalian cell culture systems based on this concept. The Phase III plan is to commercialize a series of instruments, from small bench-top scale to large scale production systems, that would meet the needs of the diagnostic and therapeutic protein manufacturers. The Phase II project has two major areas of research: The design and development of a spirally-wrapped version of the new reactor's capabilities with respect to the growth of attachment dependent cells. For the former work a number of NMR imaging and spectroscopic techniques would be developed that would allow bioreactor performance to be evaluated non-invasively. The applicants states the NMR techniques may be widely applicable to other hollow fiber bioreactors and high cell density perfusion reactors.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R44
  • Administering IC
    CA
  • Application Type
    9
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    395
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG7
  • Study Section Name
  • Organization Name
    BIOVEST INTERNATIONAL, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    Minneapolis
  • Organization State
    MN
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    55433
  • Organization District
    UNITED STATES